A randomized controlled clinical study of postoperative radiotherapy with or without sequential chemotherapy of esophageal squamous cell carcinoma

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003510

Enrollment

Unknown

Registered

2013-05-21

Start date

2013-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinoma

Interventions

1:radiotherapy after surgery

2:Adjuvant radiotherapy after surgery with sequential chemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Surgery of R0 resection, pathology proven primary thoracic esophageal squamous cell carcinoma; 2. Patients age: >= 18 years, <75 years; 3. ECOG performance status of 0-2; 4. No history of radiotherapy or chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Treated with thoracic radiotherapy, chemotherapy, targeted therapy before this test starting; 2. Postoperative over 8 weeks; 3. With tumor remain, recurrence or distant metastasis; 4. Participated in other clinical trials in past 30 days; 5. Researchers believe that should be excluded from the study of some of the obvious disease.

Design outcomes

Primary

Measure	Time frame
safety;Disease free survival;	—

Countries

China

Contacts

Public ContactPeng Feng, Xu Yong

pfwork@126.com+86 18980601767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026